The Unyvero platform developed by Curetis is a fast, comprehensive diagnostics system for severe infectious diseases in hospitalized patients.
Using a variety of cartridges, diseases such as pneumonia or implant and tissue infections can be easily and rapidly diagnosed within just four to five hours, whether this is in the laboratory or directly at the "point of need" in the hospital.
Curetis’ Subsidiary Ares Genetics Teams Up with Leading Global Pharma Company in Fight Against Antibiotic Resistance
Curetis Sharpens Focus on Near-Term Strategic Value Drivers
38ème Réunion Interdisciplinaire de Chimiothérapie Anti-Infectieuse - Paris, France - December 17 to 18, 2018
DIVI 2018- December 5 to 7, 2018, Leipzig, Germany